Elixxer Ltd.·Healthcare
Elixxer Ltd. operates as a cannabis investment firm in Canada, Australia, Italy, Jamaica, and Switzerland. It invests in cannabis-related businesses, which are fully licensed for cultivation, production, and/or sale of medical and specialty cannabis and cannabis-derived products in the pharmaceutical sector. The company was formerly known as LGC Capital Ltd. and changed its name to Elixxer Ltd. in August 2019. Elixxer Ltd. was incorporated in 2004 and is based in Montreal, Canada.
Healthcare
Drug Manufacturers - Specialty & Generic
2017-12-14
-0.54

Toronto, Ontario--(Newsfile Corp. - February 2, 2026) - Elixxer Ltd. (TSXV: ELXR.H) ("Elixxer" or the "Company") announces that, further to its press release of July 4, 2025, the Company has entered into an amending agreement dated January 29, 2026 (the "Amending Agreement") with an effective date of January 1, 2026, with AIP Asset Management Inc. (the "Security Agent") and AIP Convertible Private Debt Fund L.P.

Toronto, Ontario--(Newsfile Corp. - January 14, 2026) - Elixxer Ltd. (TSXV: ELXR.H) ("Elixxer" or the "Company") is pleased to announce that, further to its press release of September 5, 2025, September 16, 2025 and November 6, 2025, it has settled an aggregate of $6,923,742.46 through the issuance of an aggregate of 83,924,151 common shares (each, a "Common Share") at a deemed issuance price of $0.0825 per Common Share (the "Debt Settlement").